Dementia Medication Overview (cont.)
IN THIS ARTICLE
Author: Richard J Caselli, MD, Professor, Department of Neurology, Mayo Medical School, Rochester, MN; Chair, Department of Neurology, Mayo Clinic of Scottsdale.
Authors and Editors
Coauthor(s): Mary L Windle, Pharm D, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Pharmacy Editor, eMedicine.com, Inc.
Editors: Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Helmi L Lutsep, MD, Associate Director, Oregon Stroke Center; Associate Professor, Department of Neurology, Oregon Health and Science University.
Last Editorial Review: 10/27/2005
Richard J Caselli, MD
Mary L Windle, PharmD
Nicholas Y Lorenzo, MD
Francisco Talavera, PharmD, PhD
Helmi L Lutsep, MD
Must Read Articles Related to Dementia Medication Overview
Read What Your Physician is Reading on Medscape
Perhaps the most important challenge in treating dementia is identifying cases (albeit uncommon) of reversible dementia such as chronic drug intoxication, vitamin deficiencies (B-12 and folate), subdural hematoma(s), major depression (causing forgetfulness), normal pressure hydrocephalus (NPH), and hypothyroidism.